Edesa Biotech, Inc. Common Shares (NASDAQ: EDSA) last traded at $3.51, down 4.10% on the session. The quote above updates while this page is open; the figures below are drawn from Edesa Biotech, Inc. Common Shares’s own filings and are restated only when a new one is published.
Edesa Biotech, Inc. Common Shares trades on NASDAQ under the ticker EDSA. Its market capitalisation is $33.84 million.
Valuation measures for Edesa Biotech, Inc. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $33.84M |
|---|---|
| Enterprise value | $27.45M |
| Price / book | 3.84 |
| Beta | -0.82 |
Trailing-twelve-month figures tagged in Edesa Biotech, Inc. Common Shares's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$14.10M |
| EPS (TTM) | -$1.61 |
|---|
| Return on equity | -160.05% |
|---|
| Cash | $10.30M |
|---|
Range and volume for EDSA over the past 52 weeks.
| 52-week high | $20.32 |
|---|---|
| 52-week low | $0.720 |
| Volume | 36.5K |
| Average volume | 61.5K |
| Previous close | $3.66 |
Invest a chosen dollar amount in Edesa Biotech, Inc. Common Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell EDSA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.